NeoProteomics is a leading name when it comes to structural mass spectrometry and protein footprinting for pharmaceutical and biotech applications.
Location: United States, Ohio, Columbus
Employees: 1-10
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Great Lake... | glideit.or... |
| - | Innovation... | innovation... |
Mentions in press and media 3
| Date | Title | Description |
| 29.03.2011 | Case Western and bioinformatics spinoff enter licensing deal | A bioinformatics spinoff company from Case Western Reserve University has reached an exclusive option agreement to license technology from the university. The company, NeoProteomics, was co-founded by Mark Chance, director of Case Center fo... |
| 11.09.2009 | Proteomics researcher Mark Chance gets help to take technology from bench to bedside | On Thursday Mark Chance, a physiology and biophysics professor at Case Western Reserve University School of Medicine, accepted a $25,000 grant from the Innovation Fund of the Lorain County Community College Foundation. Chance plans to use... |
| - | Proteomics researcher Mark Chance gets help to take technology from bench to bedside | CLEVELAND, Ohio — Mark Chance learned to love science by hanging around the University of Pennsylvania laboratory of his uncle, Britton Chance. The elder Chance is a biophysicist who is well-known in scientific circles for his research... |